<DOC>
	<DOCNO>NCT01402232</DOCNO>
	<brief_summary>To raise optimal strategy reduction risk contrast-induced nephropathy accord several combination different risk factor clinical practice determine supply guidance clinical practice</brief_summary>
	<brief_title>Reduction Risk Contrast Nephropathy</brief_title>
	<detailed_description>1 . To identify risk factor contrast-induced nephropathy base literatures date previous research . 2 . To develop predictive model contrast-induced nephropathy coronary percutaneous coronary intervention . 3 . To raise optimal strategy reduction risk contrast-induced nephropathy accord several combination different risk factor clinical practice determine supply guidance clinical practice .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>patient agree stay hospital 13 day coronary angiography provide write informed consent pregnancy lactation intravascular administration contrast medium within previous seven day treatment metformin , aminoglycosides , Nacetylcysteine ( NAC ) , nonsteroidal antiinflammatory drug within previous 48 h intake nephrotoxic drug within previous seven day history serious reaction contrast medium severe concomitant disease renal transplantation , endstage renal disease necessitate dialysis patient die coronary angiography</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>contrast-induced nephropathy</keyword>
	<keyword>contrast medium</keyword>
	<keyword>creatinine clearance</keyword>
	<keyword>coronary angiography</keyword>
	<keyword>diabetes</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>predictive model</keyword>
</DOC>